Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural phenomenon.

The epidemic of out-of-control generative artificial intelligence in litigation filings has metastasized to a False Claims Act (FCA) lawsuit against ...

CVS Health posted strong second-quarter results and raised its full-year guidance following strong performances in its Aetna and pharmacy segments, but its healthcare delivery segment remains under ...

Footage from a cellphone was initially thought to show a storm drain being used by a homeless person—highlighting concerns in the state about homelessness.

In June, Stanford Health Care announced a partnership with Kivo Health to deliver “virtual first,” “AI powered” pulmonary rehabilitation (PR) to their patients with COPD. Stanford Health Care closed ...

Carlsmed (Nasdaq:CARL) today announced new technology add-on payment (NTAP) reimbursement for its spine implant technology.

As policymakers in the U.S. and globally consider how to govern artificial intelligence technology, Berkeley researchers have ...

Dr. Marten den Haring, an A.I. entrepreneur and CEO of Lirio, explores the U.S. government’s early efforts to modernize ...

UnitedHealth Group Incorporated (NYSE:UNH) is one of the Best 52-Week Low Blue Chip Stocks to Buy Now. On July 30, Oppenheimer analyst Michael Wiederhorn reduced the price objective on UnitedHealth ...

Medicare Advantage (MA) payer Alignment Healthcare is raising its full-year guidance across the board after its first-ever ...

Artificial Intelligence (AI) continues to revolutionize industries and is poised to bring transformative change in healthcare delivery, ...

Of the nearly 700 such devices captured in STAT’s Breakthrough Device Tracker, at least 10% use artificial intelligence. At least 16 have already been authorized by the FDA, and the unofficial count ...